IBS-D Research Study
Are you living with Irritable Bowel Syndrome with Persistent Diarrhea (IBS-D)?
If so, consider joining the Enviva study, an IBS clinical trial for people with IBS-D investigating a new potential irritable bowel syndrome treatment.
*Volunteers will receive study-related care, including the cost of the issued study drug, at no cost. Participants may receive compensation for their time and travel.
Phase 2 Clinical Research Study.
The goal of Enviva is to explore the effect of an investigational drug on the symptoms of irritable bowel syndrome with predominant diarrhea (IBS-D).
Researchers are studying how the investigational drug may help ease unpleasant symptoms, such as abdominal pain, bloating, and altered stool consistency.
Get Started
COMPLETE THE QUESTIONNAIRE
*As a IBS-D research study participant, all study-related care will be provided at no cost to you, including the study drug. Participants may receive compensation for their time and travel
"*" indicates required fields
More Research Studies Coming Soon
Screening for Colon Cancer
IBS-C
GERD
Menstrual Migraines
Diabetic Glucometer Device Study
(open to ALL ethnicities)
We will have more studies available. Click below to join the waiting list.
St. Charles Clinical Research
6034 Weldon Spring Parkway
Weldon Spring, Mo. 63304
General Inquiries
Pharmaceutical Study Experience
Abbott
Pfizer
SKK
SERES
Boston Scientific
Allergan
Merck
Biohaven
Techfield
Baxter
Furiex
Salix Pharmaceuticals
Covance
Cubist
Eli Lilly
GlaxoSmithKline
Galen
Iroko
Ironwood
Medicago
Medimmune
Novartis
Novavax
Noven Therapeutics
Seqirus USA
Teva USA
Vanda pharmaceuticals